Menu Close

Artikel-artikel mengenai SARS-CoV-2 vaccine

Menampilkan 21 - 26 dari 26 artikel

People wearing masks walk in front of Pfizer’s headquarters in New York City. Pfizer and BioNtech are on track with a vaccine that is 90 per cent effective, say preliminary results, but they are not the only ones in the race. AP Photo/Bebeto Matthews

COVID-19 vaccine update: Pfizer may be the frontrunner, but Canada has hedged its bets

Canada has set aside a total of 414 million doses of different types of vaccine. Some exploit known mechanisms, others are based on previously untested approaches.
Visitors look at new anti-SARS outfits for medical workers on display Thursday Nov. 6, 2003 in Shanghai, China, as the country braced for a resurgence. The disease never made a comeback. AP Photo/Eugene Hoshiko

The mysterious disappearance of the first SARS virus, and why we need a vaccine for the current one but didn’t for the other

COVID-19 and SARS are both deadly – but different. SARS symptoms were quick to appear, making it easier to contain. Because health officials were able to contain it, the virus died off.

Kontributor teratas

Lebih banyak